Vymada, a combination of sacubitril and valsartan, is prescribed for hypertension and heart failure.
This Site is Intended for Healthcare Professionals Only
Search
AI Powered
Human content,
AI powered search.
Latest Stories
Start your day right!
Get the latest updates and insights delivered to your inbox
Former health secretary Jeremy Hunt
GettyImages
AstraZeneca announced in July it would invest $50 billion in the United States by 2030
Pic credit: Gettyimages
The variant now makes up 76.1 per cent of infections, up from 49.3 per cent just six weeks ago
Getty Images
×
Terms and Conditions
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Asian Trade
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at
data@amg.biz
to see how we manage and store your data.
×
Terms and Conditions
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Asian Trade
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.